Why You Need To Look At This Metric Before Buying Patterson Companies Inc. (NASDAQ:PDCO)

Patterson Companies Inc. (NASDAQ:PDCO) Relative Strength Index (RSI) is 43.32, with weekly volatility at 2.65% and ATR at 0.98. The PDCO stock’s 52-week price range has touched low of $17.06 and a $37.16 high. Intraday shares traded counted 0.89 million, which was -20.86% lower than its 30-day average trading volume of 733.61K. Its shares traded lower over the last trading session, losing -1.59% on 05/25/21. The shares fell to a low of $33.365 before closing at $33.45. PDCO’s previous close was $33.99 while the outstanding shares total 95.73M. The firm has a beta of 1.56.

Investors have identified the Medical Distribution company Patterson Companies Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $3.29 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Patterson Companies Inc. (PDCO) Fundamentals that are to be considered.

When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For PDCO, the company has in raw cash 155.96 million on their books with 208.75 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.72 billion total, with 1.2 billion as their total liabilities.

Having a look at the company’s valuation, the company is expected to record 2.12 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on PDCO sounds very interesting.

Is the stock of PDCO attractive?

In related news, VP, General Counsel, KORSH LES B sold 1,174 shares of the company’s stock in a transaction that recorded on Apr 26. The sale was performed at an average price of 33.65, for a total value of 39,505. As the sale deal closes, the Chief Financial Officer, Zurbay Donald now sold 6,817 shares of the company’s stock, valued at 205,173. Also, Director, FERAGEN JODY H sold 10,052 shares of the company’s stock in a deal that was recorded on Jan 13. The shares were price at an average price of 32.83 per share, with a total market value of 329,986. Following this completion of acquisition, the VP, General Counsel, KORSH LES B now holds 3,111 shares of the company’s stock, valued at 78,025. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.80%.

State Reviewer
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.